Omalizumab effectiveness in Asthma COPD overlap: post hoc analysis of PROSPERO study

Patients with asthma and COPD overlap (ACO) are poorly represented in asthma clinical trials. This post hoc analysis of a large, real-world study demonstrates that omalizumab may be beneficial in patients with ACO. (Source: Journal of Allergy and Clinical Immunology)

MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.

from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2USP74F